ClinicalTrials.gg
Active, not recruitingNCT05977153Updated Nov 6, 2026

CT for Personalized Mechanical Ventilation

An interventional study of PEEP (positive end-expiratory pressure) - maximum and PEEP (positive end-expiratory pressure) - standard in Ventilator-Induced Lung Injury, Sepsis Syndrome and Mechanical Ventilation Complication, sponsored by The University of Texas Medical Branch, Galveston. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Prevention

How we know

Updated Nov 6, 2026Sponsor changed1 site added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Ventilator-Induced Lung Injury with a site in United States — 4 open to participants now, 6 under way, none of them phase 3. Ventilator-Induced Lung Injury · United States.

Enrollment
15th of 18
7 · median 31
Started
2023
with 2 others
No phase
14 of 23
3 open now
Registered
20th of 23
by date
Lead sponsor
2 of 23
The University of Texas Medical Branch, Galveston

Among the 23 studies in Ventilator-Induced Lung Injury with a site in United States, this one is the 15th largest by enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2023, is one of 14 with no phase, and was the 20th registered.

Ventilator-Induced Lung Injury

122 studies on the registry are indexed under Ventilator-Induced Lung Injury; 40 are open to participants now.

Browse Ventilator-Induced Lung Injury studies →

Open to participants now

4 of the 23 studies in Ventilator-Induced Lung Injury with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 22 Ventilator-Induced Lung Injury studies recruiting now, 15 (68%) set no upper age limit and 5 (23%) stop at 75 or younger; 5 take children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Ventilator-Induced Lung Injury with a site in United States, or all of them as a file.
02

Study summary

The goal of this study is to compare two different ways of helping patients with a condition called sepsis who need help breathing using a machine called a ventilator. The investigators want to study which way of setting the ventilator is better for the lungs.

Here are the main questions the investigators want to answer:

  1. How does the amount of air in the lungs and the way it moves differ between the two ways?
  2. How does the way air spreads out in different parts of the lungs differ between the two ways? In this study, the investigators will take special pictures of the lungs using a machine called a CT scan. The pictures will show us how much the lungs stretch and how much air is in different parts of the lungs. The investigators will compare two different ways of using the ventilator: one personalized for each patient based on their breathing, and another way that is commonly used.

By comparing these two ways, the investigators hope to learn which one is better for helping patients with sepsis who need the ventilator. This information can help doctors make better decisions about how to care for these patients and improve their breathing.

Read the detailed description

Mechanical ventilation is a key life support method applied to millions of surgical and critically ill patients. Ventilator-induced lung injury (VILI) is a major factor for morbidity and mortality in patients with the acute respiratory distress syndrome (ARDS), the most severe form of respiratory dysfunction. Furthermore, mechanical ventilation settings also contribute to the risk for postoperative pulmonary complications (PPCs) in surgical patients and lung injury in critically ill patients with normal lungs at onset of ventilation. In summary, mitigation of VILI is critical to reduce perioperative and critical care morbidity and mortality, with major impact on outcomes and health care costs.

In this project, we propose to apply novel CT methods to assess spatial distributions of strain and aeration and establish measures of global lung mechanics best indicative of the PEEP leading to least injurious distributions and, thus, least VILI.

03

Conditions studied

  • Ventilator-Induced Lung Injury
  • Sepsis Syndrome
  • Mechanical Ventilation Complication

Keywords

  • Computed Tomography
  • Registration Analysis
  • Functional Lung Imaging
  • Acute Lung Injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Following onset of mechanical ventilation and not longer than 5 days after intubation.
  • Sepsis as defined by the most recent criteria:

    • Life-threatening organ dysfunction caused by a dysregulated host response to infection operationalized by presumed or documented infection and a Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score >= 2 or a change by 2 from the baseline if baseline known to be different from 0;

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years;
  • Hemodynamic instability, defined as: systolic blood pressure (SBP) \< 90 mmHg that is not adequately stabilized by vasopressors or inotropic agents. For these purposes, SBP will not be considered "adequately stabilized" if the dose of the vasopressor/inotrope has not been stable for at least one hour;
  • Hypoxemia, defined as: PaO2 \< 70 mmHg on an inspired oxygen fraction (FiO2) greater than or equal to 0.9;
  • Hemodynamic and/or respiratory instability (as defined, in items 2 and 3) that develop when the patient is mobilized during routine nursing care such as repositioning/washing the patient or changing their bed linens;
  • Hemodynamic and/or respiratory instability (as defined, in items 2 and 3) that develop when a 20 second respiratory pause is required to implement the study protocol. This will be tested by inducing such a pause prior to transporting the patient;
  • Any acute or chronic condition which, in the opinion of the investigators, might confound the imaging measurements (such as, but not limited to, severe bronchospasm, pulmonary infection, and lung tumor);
  • Any acute or chronic condition which, in the opinion of the investigators or managing critical care team, could prevent safe transport to the CT suite.
  • "Air leaks" requiring tube thoracotomy (e.g., pneumothorax, bronchopleural fistula);
  • > 40 kg/m2;
  • Pregnancy (since this is a study that would expose a fetus to radiation risk);
  • Patients who have taken part in other research studies involving radiation exposure, or those patients for whom this research radiation history is unavailable at the time of consent.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
7 participants (actual)

Study arms

  • Active comparator
    Group 1: ARDSNet

    Participants will receive standard ARDSNet low-stretch PEEP (positive end-expiratory pressure) protocol.

    Procedure: PEEP (positive end-expiratory pressure) - standard

  • Experimental
    Group 2: Individualized PEEP (positive end expiratory pressure) Strategy

    Participants will receive individualized PEEP (positive end-expiratory pressure).

    Procedure: PEEP (positive end-expiratory pressure) - maximum

Interventions

  • ProcedurePEEP (positive end-expiratory pressure) - maximum

    Breathing assistance from the breathing assist machine using a method in which doctors try to find the pressures that expands the lungs the best. This is based on measurements of one's respiratory pressures and volumes. This is done by adjusting the pressure settings. This allows one's lungs to expand with the least amount of change in pressure during breathing. PEEP (positive end-expiratory pressure) will be set at the maximum static respiratory system compliance (Crs) during a descending PEEP titration curve.

  • ProcedurePEEP (positive end-expiratory pressure) - standard

    Breathing assistance from the breathing assist machine using the pressure settings typical for your disease. Standard ARDSNet low-stretch PEEP (positive end-expiratory pressure) protocol: PEEP will be set following a routinely used PEEP table according to patients' blood oxygenation status.

06

What researchers measure

Primary outcomes

  1. Squared coefficient of variation of the tidal volumetric strain

    Squared coefficient of variation (=variance normalized by the squared mean) of the tidal volumetric strain will be obtained and calculated from CT images.

    Time frame: 48 hours

Secondary outcomes

  1. Squared coefficient of variation of aeration

    Squared coefficient of variation (=variance normalized by the squared mean) of aeration obtained and calculated from CT images.

    Time frame: 48 hours

  2. Average gas fraction

    Average gas fraction will be obtained and calculated from CT images.

    Time frame: 48 hours

  3. Distribution of aeration categories

    Distribution of aeration categories (non-aerated, poorly aerated, normally aerated and hyperinflated regions) will be obtained and calculated from CT images.

    Time frame: 48 hours

  4. Average tidal strain

    Average of voxel level volumetric tidal strain will be obtained and calculated from CT images.

    Time frame: 48 hours

Other outcomes

  1. Time during mechanical ventilation

    Time during mechanical ventilation will be recorded in days.

    Time frame: Up to 5 days

  2. Detection of Inflammatory cytokines

    Inflammatory cytokine is a type of signaling molecule (a cytokine) that is secreted from immune cells like helper T cells (Th) and macrophages, and certain other cell types that promote inflammation; their presence will be measured by assays.

    Time frame: 48 hours

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — This is a NIH funded study. Data sharing will follow NIH guidelines.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Aug 2027, 51 months after the start.

Of 40 interventional studies with no phase under Ventilator-Induced Lung Injury, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 53. This study's planned 51 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 28, 2023
First posted
Aug 4, 2023
StartActual
May 10, 2023
Primary completionEst.
Aug 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • The University of Texas Medical Branch · Galveston, United States
Show 1 removed
  • Columbia University · New York, United States
Nov 6, 2026
Sponsor
Columbia University→The University of Texas Medical Branch, Galveston
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    1 site added, 1 site removed
    Show site
    • The University of Texas Medical Branch · Galveston, United States
    Show 1 removed
    • Columbia University · New York, United States
    Sponsor Columbia University→The University of Texas Medical Branch, Galveston
    + 3 other changes: identifiers, verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05977153
Responsible party
Sponsor
First posted
Aug 4, 2023
Start date
May 10, 2023
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Marcos Vidal Melo, MD, PhD
principal investigator · University of Texas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion